RemedyMD to Unveil Electronic Health Record System for Medical Researchers at HIMSS 2006
Posted on: Tuesday, 7 February 2006, 12:00 CST
SALT LAKE CITY, Feb. 7 /PRNewswire/ -- RemedyMD, an innovative provider of web-based decision support tools for clinicians, today announced ResearchEHR(TM), a specialty, condition, and disease specific software application that dramatically improves the productivity of medical researchers. ResearchEHR is the industry's first product to aggregate clinical and research findings in the same database. The new product will be unveiled in booth #7406 at the upcoming HIMSS 2006 Annual Conference and Exhibition.
Specifically designed for medical researchers within large healthcare institutions, teaching hospitals, or research-focused hospitals, ResearchEHR is an intelligent software application that combines the power of an Electronic Health Record with the tools necessary to improve researcher productivity. The system is designed to reduce the time between research discoveries in the labs and delivering those breakthroughs at the point of patient care.
Using ResearchEHR, specialty or disease-specific studies can be setup quickly with its powerful and flexible customization tools. For example, a research group focused on Chronic Obstructive Pulmonary Disorder (COPD) can quickly create their own COPD specific application that tracks only the fields that are specific to this condition. The product also includes the ability to track heredity and compare genomic data for diseases that have known or possible genetic markers. ResearchEHR is integrated with MyHealthManager(TM), a patient portal available from RemedyMD, which assists researchers in aggregating patient behavior information while improving study participation. The purpose of collecting and aggregating clinical, research, and patient data is to expose patterns not previously identified. This in turn leads to making better and more timely decisions that can improve outcomes.
"ResearchEHR replaces myriad databases and 'home grown' applications that exist in large research institutions. Since it's already specific to each specialty or disease, there's never a need for a researcher to create their own database," said Gary D. Kennedy, President and CEO of RemedyMD. "In addition our solution aggregates clinical information from point of care systems with data collected by medical researchers in order to guide their research toward the most promising areas."
ResearchEHR's open architecture allows research data to be stored in the same database as clinical data from various sources, such as a legacy EMR systems, monitoring devices, patient portals, and Hospital Information Systems. This makes real-time clinical data available to the researcher. Furthermore, its interactive graphing and reporting tools are ideal for specialized and enterprise-wide analytical needs. Sophisticated statistical analysis and knowledge discovery tools allow computation of previously unrecognized disease patterns, identify patient cohorts, or form hypotheses based upon hidden data trends.
ResearchEHR is immediately available. For more information, visit RemedyMD at HIMSS in booth number #7406 or visit RemedyMD on the Web at http://www.remedymd.com/.
About RemedyMD
RemedyMD is transforming healthcare by delivering intelligent, decision-support software that enables medical professionals to make better decisions -- ultimately leading to better outcomes. Using RemedyMD, physicians are reviewing the latest patient and research trends at the point of care; researchers are introducing point-of-care information into their medical studies; and patients are receiving more relevant, personalized information as they take greater responsibility for their own health. Using predictive informatics, RemedyMD is helping professionals take preemptive actions, reducing the system-wide cost of healthcare. RemedyMD web-based software has a low cost of ownership and is personalized to specific practices and medical specialties. Visit http://www.remedymd.com/.
Editorial contact Alex Koritz Sprout Marketing for RemedyMD alex@sproutmarketing.com (801) 641-3808
RemedyMD
CONTACT: Alex Koritz of Sprout Marketing, +1-801-641-3808,alex@sproutmarketing.com, for RemedyMD
Web site: http://www.remedymd.com/
Source: PRNewswire
Related Articles
- Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
- BDSI Names David Blum, M.D. Vice President of Medical Affairs and Clinical Research
- Foundation for Clinical Research in Inflammatory Bowel Disease Launches MyIBD.Org
- Cepheid Launches GeneXpert(R) System in the Molecular Clinical Research Field
- A Normative Justification for Distinguishing the Ethics of Clinical Research
- Company Profile for Harrison Clinical Research
- Food and Drug Administration and Duke Clinical Research Institute to Host a Cardiac Safety Think Tank
- Cerus Corporation Appoints Dr. Joseph Eiden Vice President, Clinical Research and Medical Affairs
- Chinese Anti-Cancer Vaccine Approved for Clinical Research
- Advantages of confidence intervals in clinical research
User Comments (0)

RSS Feeds